Answers are grounded in this paper and cite their sources.
This in vitro study evaluated how Er,Cr:YSGG irradiation at three energy levels (1, 3, and 6 J/cm2), 810 nm diode irradiation, and their combinations can influence human osteoblast viability and osteogenic activity. Human osteoblasts (hOB) were assigned to eight groups: control, diode, Er,Cr:YSGG at 1, 3, and 6 J/cm2, and each Er,Cr:YSGG dose followed immediately by diode irradiation. 24 h after irradiation, metabolic activity (MTT), membrane integrity (LDH), nitric oxide (NO) production, and alkaline phosphatase (ALP) activity were assessed, and cell morphology was tracked by holographic live-cell imaging. Cell viability and membrane integrity were preserved across all protocols (MTT p = 0.325; LDH p = 0.057; both n.s.), and live-cell imaging showed osteoblast morphology and proliferation. Diode irradiation significantly increased ALP activity versus control (12.96 vs. 5.40 IU/L; p = 0.011), confirming a biostimulatory osteogenic effect, whereas Er,Cr:YSGG at 6 J/cm2 almost completely suppressed ALP activity (0.42 IU/L; p < 0.001 vs. diode). Both Er,Cr:YSGG 3 J + diode and 6 J + diode combinations significantly attenuated the diode-induced ALP increase and NO elevation in a dose-dependent manner. No protocol was cytotoxic. The 810 nm diode laser was the most osteogenically favorable condition, whereas higher-energy Er,Cr:YSGG irradiation suppressed ALP activity and, when combined with the diode, attenuated its osteogenic effect.
No takes yet. Share an insight, caveat, or question.
Totan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: